DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vepesid (Etoposide) - Leukopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Leukopenia (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vepesid (Etoposide) where reactions include leukopenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vepesid side effects in 72 year old female

Reported by a consumer/non-health professional from Norway on 2012-06-01

Patient: 72 year old female

Reactions: Anaemia, Hepatic Failure, Haematotoxicity, Renal Failure, Respiratory Failure, Sepsis, Neutropenia, Septic Shock, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Vepesid
    Dosage: 100 mg/m2 also 350mg:17-mar12 to 18mar12(also 200mg/m2):2dys 1-3
    Indication: Lung Neoplasm Malignant
    Start date: 2012-03-16

Cisplatin
    Dosage: 75 mg/m*2
    Indication: Lung Neoplasm Malignant
    Start date: 2012-03-16

Other drugs received by patient: Acetaminophen; Metoprolol Succinate; Adalat; Tramadol HCL; Enalapril Maleate; Simvastatin; Aspirin



Possible Vepesid side effects in 5 year old female

Reported by a physician from Japan on 2012-03-16

Patient: 5 year old female

Reactions: Hemiparesis, Superior Sagittal Sinus Thrombosis, Convulsion, Leukopenia

Drug(s) suspected as cause:
Vepesid
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Cisplatin
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS



Possible Vepesid side effects in 12 year old female

Reported by a consumer/non-health professional from Japan on 2012-03-16

Patient: 12 year old female

Reactions: Subdural Haematoma, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Ifosfamide
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Vepesid
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Cisplatin
    Dosage: on day one
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS



Possible Vepesid side effects in 12 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-16

Patient: 12 year old male

Reactions: Subdural Haematoma, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Vepesid
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Ifosfamide
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Cisplatin
    Dosage: on day one
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS



Possible Vepesid side effects in 5 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-10

Patient: 5 year old female

Reactions: Hemiparesis, Superior Sagittal Sinus Thrombosis, Leukopenia, Convulsion

Drug(s) suspected as cause:
Vepesid
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Cisplatin
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS



Possible Vepesid side effects in 12 year old female

Reported by a consumer/non-health professional from Japan on 2012-03-10

Patient: 12 year old female

Reactions: Subdural Haematoma, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Ifosfamide
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Cisplatin
    Dosage: on day one
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Vepesid
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS



Possible Vepesid side effects in 12 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-10

Patient: 12 year old male

Reactions: Subdural Haematoma, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Vepesid
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Ifosfamide
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS

Cisplatin
    Dosage: on day one
    Indication: Nongerminomatous Germ Cell Tumour of THE CNS



Possible Vepesid side effects in 16 year old female

Reported by a physician from Switzerland on 2011-12-21

Patient: 16 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Histiocytosis Haematophagic, Anaemia, Rash, Pyrexia, Odynophagia, Mucosal Inflammation, Multi-Organ Failure, Toxoplasmosis, Cardiac Failure, Alopecia, Granulocytopenia, Acute Respiratory Distress Syndrome, Dizziness, Abscess, Thrombocytopenia, Leukopenia, Inflammation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Celebrex
    Indication: Cartilage Neoplasm

Isotretinoin
    Dosage: 60 mg, 2x/day
    Administration route: Oral
    Indication: Bone Neoplasm Malignant
    Start date: 2011-08-15
    End date: 2011-08-28

Vepesid
    Dosage: 31 mg 2x every third day
    Indication: Bone Neoplasm Malignant
    Start date: 2011-08-15
    End date: 2011-08-31

Vepesid
    Indication: Cartilage Neoplasm

Isotretinoin
    Indication: Cartilage Neoplasm

Celebrex
    Dosage: 300 mg, alternate day
    Administration route: Oral
    Indication: Bone Neoplasm Malignant
    Start date: 2011-08-16
    End date: 2011-09-03



Possible Vepesid side effects in 16 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2011-12-21

Patient: 16 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Histiocytosis Haematophagic, Anaemia, Odynophagia, Rash Macular, Multi-Organ Failure, Toxoplasmosis, Mucosal Inflammation, Cardiac Failure, Granulocytopenia, Alopecia, Acute Respiratory Distress Syndrome, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vepesid
    Indication: Bone Sarcoma
    Start date: 2011-08-15
    End date: 2011-08-31

Isotretinoin
    Administration route: Oral
    Indication: Bone Sarcoma
    Start date: 2011-08-15
    End date: 2011-08-28

Other drugs received by patient: Celebrex

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017